LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Accueil・Liste d'Actions・Verve Therapeutics Inc

Search

Verve Therapeutics Inc

Fermé

5.63 2.36

Résumé

Variation du prix de l'action

24h

Actuel

Min

5.61

Max

5.73

Recommandations
By TipRanks
Recommandations	Achat Fort
Prévisions sur 12 Mois	+284.27 upside

Dividendes
By Dow Jones
Prochains Résultats	7 nov. 2024

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

4.94 / 6.08 Support & Résistance

Verve Therapeutics Inc Graphique

Actualités Associées

29 nov. 2023, 11:32 UTC

Principaux Mouvements du Marché

Verve Therapeutics Shares Tumble Premarket After Stock Sales

31 oct. 2023, 10:44 UTC

Acquisitions, Fusions, Rachats

Beam Therapeutics to Sell Rights in Verve Licensing Deal to Lilly for $250 Million Upfront

29 nov. 2023, 03:45 UTC

Acquisitions, Fusions, Rachats

Verve Offering, Placement to Close on December 1 >VERV

29 nov. 2023, 03:45 UTC

Acquisitions, Fusions, Rachats

Verve: Jefferies, Guggenheim Securities Among Managers for Offering >VERV

29 nov. 2023, 03:45 UTC

Acquisitions, Fusions, Rachats

Verve: Aggregate Proceeds From Offering, Private Placement Seen at $148.0M >VERV

29 nov. 2023, 03:44 UTC

Acquisitions, Fusions, Rachats

Verve to Sell 2,296,317 Shrs to Eli Lilly for Gross Proceeds of About $23.0M >VERV

31 oct. 2023, 10:29 UTC

Acquisitions, Fusions, Rachats

Beam Therapeutics to Sell Rights in Verve Licensing Deal to Lilly for $250M Upfront

Comparaison

Variation de prix

Verve Therapeutics Inc prévision

Objectif de Prix

By TipRanks

284.27% hausse

Prévisions sur 12 Mois

Moyen 21.25 USD 284.27%

Haut 29 USD

Bas 15 USD

Basé sur 4 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

4 ratings

4

Achat

0

Maintien

0

Vente

Basé sur 4 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Score Technique

By Trading Central

4.94 / 6.08Support & Résistance

Recent bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

There are no events.

Autres valeurs du secteur

LLY

Eli Lilly and Co.

902.74

UNH

UnitedHealth Group Inc

596.8

NVO

Novo Nordisk A-S

131.05

JNJ

Johnson and Johnson

164.37

ABBV

AbbVie Inc

193.18